Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2003
11/27/2003WO2003097676A1 Polypeptide antigen inducing hiv neutralizing antibodies
11/27/2003WO2003097675A1 Fusion protein of hiv regulatory/accessory proteins
11/27/2003WO2003097674A1 A purified polypeptide, isolated nucleic acids encoding said polypeptide, vectors and use thereof
11/27/2003WO2003097673A2 Chimeric human papillomavirus 16 l1 proteins comprising an l2 peptide,virus-like particles prepared therefrom and a method for preparing the particles.
11/27/2003WO2003097669A2 Method for purifying denatured proteins having a desired disulfide bond configuration
11/27/2003WO2003097668A2 Novel process for production of the somatostatin analog, octreotide
11/27/2003WO2003097665A2 Mid 241 receptor, a novel g-protein coupled receptor
11/27/2003WO2003097091A2 Glucan-based vaccines
11/27/2003WO2003097090A1 Use of modified novirhabdoviruses to obtain vaccines
11/27/2003WO2003097089A2 Attenuation of metapneumovirus
11/27/2003WO2003097087A1 Bcg vaccine and utilization thereof
11/27/2003WO2003097086A2 Egf receptor antagonists in the treatment of gastric cancer
11/27/2003WO2003096986A2 Compositions and methods for treatment of wounds
11/27/2003WO2003096974A2 ORIENTIA TSUTSUGAMUSHI TRUNCATED RECOMBINANT OUTER MENBRANE PROTEIN (r47) AND (r56) VACCINES DIAGNOSTICS AND THERAPEUTICS FOR SCRUB TYPHUS AND HIV INFECTION
11/27/2003WO2003096869A2 Recombinant bet. v. 1. allergen mutants, methods and process thereof
11/27/2003WO2003096808A1 Prevention or treatment of abnormal lipoprotein, cholestasis and atherosclerosis
11/27/2003WO2003096804A1 Heparin-binding epidermal growth factor-like growth factor gene-modified animal, screening method, embryonic stem cells and preventive and/or remediy for heart failure
11/27/2003WO2003096797A2 Method of increasing plant organ and seed size in a plant
11/27/2003WO2003085087A3 Modified cea nucleic acid and expression vectors
11/27/2003WO2003080828A3 Nucleic acid molecules involved in the synthesis of melithiazols
11/27/2003WO2003080669A3 Anti-hpv-16 e7 antibodies and their use
11/27/2003WO2003080570A3 Recombinant expression vectors for functional nav1.9 sodium channels
11/27/2003WO2003079748A3 Potentiation of cancer therapies by znf217 inhibition
11/27/2003WO2003078580A3 Imprinting in plants to control gene expression
11/27/2003WO2003078568A3 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
11/27/2003WO2003076598A3 Method of inducing an enhanced immune response against hiv
11/27/2003WO2003076563A3 Human protooncogene and protein encoded therein
11/27/2003WO2003075841A3 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
11/27/2003WO2003074725A3 MBCATs AS MODIFIERS OF THE BETA-CATENIN PATHWAY AND METHODS OF USE
11/27/2003WO2003074547A3 Biologically active complex comprising alpha-lcatalbumin or a variant thereof, and a cofactor
11/27/2003WO2003072828A3 Fcgammariib polymorphisms detection in system lupus erythematosus
11/27/2003WO2003072594A3 An obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity
11/27/2003WO2003070765A3 Growth hormone fusion protein
11/27/2003WO2003070176A3 Modified defensins and their use
11/27/2003WO2003068940A3 Complexes and methods of using same
11/27/2003WO2003068802A3 Materials and methods for preparing dimeric growth factors
11/27/2003WO2003064676A3 Diagnostic and therapeutic methods using the h37 tumor suppressor gene
11/27/2003WO2003062270A3 Fluorescent protein from aequorea coerulscens and uses therof
11/27/2003WO2003062268A3 Corticotropin releasing factor receptor 2 agonists
11/27/2003WO2003061590A3 Peptide constructs for treating disease
11/27/2003WO2003061583A9 Digenic mutations associated with severe insulin resistance and type 2 diabetes and their use in the diagnosis and treatment of diabetes
11/27/2003WO2003059378A3 Combined use of a glp-1 compound and another drug for treating dyslipidemia
11/27/2003WO2003056020A3 Expression vectors and promoters for heterologous gene expression
11/27/2003WO2003055505A3 Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders
11/27/2003WO2003054010A3 Early stage redox-related apoptosis modulator-2 (esram-2)
11/27/2003WO2003054004A3 Secreted proteins
11/27/2003WO2003053338A3 Novel chimeric rev, tat, and nef antigens
11/27/2003WO2003052083A3 Methods for the generation of proliferating and differentiating cell lines
11/27/2003WO2003052079A3 Mutants of human insulin-like growth factor binding protein-3 (igfbp-3) and uses thereof
11/27/2003WO2003048368A3 Plants having altered abscisic acid (aba) sensitivity
11/27/2003WO2003048178A3 Nucleotide analogues and their use for nucleic acid sequencing
11/27/2003WO2003046212A3 Method for identifying target epitopes of the t cell mediated immune response and for assaying epitope-specific t cells
11/27/2003WO2003046176A3 Protein-protein interactions in human immunodeficiency virus
11/27/2003WO2003046150A3 Glycoprotein remodeling using endoglycanases
11/27/2003WO2003044214A3 Methods and compositions in checkpoint signaling
11/27/2003WO2003043986A3 Polypeptides of moraxella (branhamella) catarrhalis
11/27/2003WO2003042249A3 Peptide purification by means of metal ion affinity chromatography
11/27/2003WO2003040299A3 Method of selecting hla-dp4 ligands and the applications thereof
11/27/2003WO2003037932A3 Human coagulation factor vii polypeptides
11/27/2003WO2003035883A3 Methods and compositions for inducing tumor-specific cytotoxicity
11/27/2003WO2003034275A3 Chimeric glycosylphosphatidylinositol containing peptides
11/27/2003WO2003032964A3 Gap junctions and endothelial-derived hyperpolarizing factor (edhf)
11/27/2003WO2003031578A3 Mammalian c-type lectins
11/27/2003WO2003031573A3 Toll-like receptor 3 signaling agonists and antagonists
11/27/2003WO2003030932A9 Attenuated mutant newcastle disease virus strains for in ovo vaccination, method for preparing and their use
11/27/2003WO2003030824A3 Methods and compositions for treating dermal lesions
11/27/2003WO2003029464A3 Genes associated with mast cell activation
11/27/2003WO2003029463A3 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
11/27/2003WO2003029276A3 Copolymers for suppression of autoimmune diseases, and methods of use
11/27/2003WO2003027147A3 Human coagulation factor vii polypeptides
11/27/2003WO2003023027A3 Tt virus sequences in human tumoral tissue, agent for the detection thereof and tumoral therapy
11/27/2003WO2003022868A3 Metal binding proteins and associated methods
11/27/2003WO2003020759A3 A caspase- 8 binding protein, its preparation and use
11/27/2003WO2003018746A3 Estrogen receptor alpha variants and methods of detection thereof
11/27/2003WO2003018636A3 Chimaeric peptides of insulin, their compositions and use in treating diabetes
11/27/2003WO2003016481A3 Novel human collagen proteins and polynucleotides encoding the same
11/27/2003WO2003016342A3 Tumor antigens for prevention and/or treatment of cancer
11/27/2003WO2003014144A3 Molecule
11/27/2003WO2003013590A8 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer
11/27/2003WO2003012064A3 Nucleic acids and encoded polypeptides associated with bipolar disorder
11/27/2003WO2003010200A3 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
11/27/2003WO2003010195A3 Novel compounds
11/27/2003WO2003008443A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/27/2003WO2003008435A3 Gfp fusion proteins and their use
11/27/2003WO2003006620A3 Linear and cyclic melanocortin receptor-specific peptides
11/27/2003WO2003004091A3 Aromatic sulfenates for type i phototherapy
11/27/2003WO2003003977A3 Compositions and methods for the treatment of body weight disorders, including obesity
11/27/2003WO2002102299A3 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
11/27/2003WO2002101079A3 Anti-apoptosis genes and methods of use thereof
11/27/2003WO2002099066A3 20 human secreted proteins
11/27/2003WO2002097057A3 Gene and polypeptide which opposes the fas pathyway
11/27/2003WO2002097041A3 Fusion proteins of biologically active peptides and antibodies
11/27/2003WO2002092626A3 Cleavage and polyadenylation complex of precursor mrna
11/27/2003WO2002092147A3 Optimization of the molecular properties and formulation of proteins delivered by inhalation
11/27/2003WO2002092004A8 Use of hmg fragment as anti-inflammatory agents
11/27/2003WO2002088361A3 Haemophilus influenzae antigens
11/27/2003WO2002086156A3 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
11/27/2003WO2002086113A3 Enzyme and snp marker for disease
11/27/2003WO2002085940A3 New polynucleotides and polypeptides of the erythropoietin gene
11/27/2003WO2002083731A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
1 ... 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 ... 2916